IceCure Medical (ICCM) Invested Capital (2020 - 2025)

IceCure Medical (ICCM) has 6 years of Invested Capital data on file, last reported at $9.1 million in Q4 2025.

• Invested Capital for Q4 2025 came in at $9.1 million, up 31.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $9.1 million (up 31.15% YoY), and the FY2025 annual result was $9.1 million, up 31.15% from the prior year.
• Invested Capital advanced to $9.1 million in Q4 2025 per ICCM's latest filing, from $6.9 million in the prior quarter.
• Over five years, Invested Capital peaked at $27.0 million in Q4 2021 and troughed at $6.9 million in Q4 2024.
• A 5-year average of $16.1 million and a median of $12.2 million in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2021 and 2023: Invested Capital jumped 377.3% in 2021, then plunged 52.16% in 2023.
• A 5-year view of Invested Capital shows it stood at $27.0 million in 2021, then decreased by 5.7% to $25.4 million in 2022, then plunged by 52.16% to $12.2 million in 2023, then sank by 43.26% to $6.9 million in 2024, then jumped by 31.15% to $9.1 million in 2025.
• Business Quant data shows ICCM's Invested Capital at $9.1 million in Q4 2025, $6.9 million in Q4 2024, and $12.2 million in Q4 2023.